Compagnie Lombard Odier SCmA’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-1,500	Closed	-$90K	–	955
2016 Q1	$90K	Buy	+1,500	New	+$91.8K	﹤0.01%	636

Other funds holding PJP

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NFC

Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

MWM

Merriman Wealth Management Seattle, Washington $2.4B AUM 13.66% 1-Year Est. Return

Compagnie Lombard Odier SCmA's PJP Position: Q2 2016 in Review

Compagnie Lombard Odier SCmA sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2016, closing a stake of 1,500 shares — an estimated $90K sold.

Compagnie Lombard Odier SCmA first reported a position in PJP in Q1 2016 and held it in 1 quarter. The position peaked at $90K in Q1 2016. 97 funds tracked by Wall St. Rank hold PJP as of Q2 2016.

Compagnie Lombard Odier SCmA reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2016 after selling out during the quarter.
Compagnie Lombard Odier SCmA sold 1,500 Invesco Pharmaceuticals ETF shares in Q2 2016, an estimated $90K.
Compagnie Lombard Odier SCmA first reported a position in Invesco Pharmaceuticals ETF in Q1 2016 and held it in 1 quarter.
Compagnie Lombard Odier SCmA's Invesco Pharmaceuticals ETF position peaked at $90K in Q1 2016.
97 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2016.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q2 2016, filed 15 Aug 2016.